Basel Medical (BMGL) Equity Ratio (2024 - 2025)
Basel Medical's (BMGL) quarterly Equity Ratio came in at 0.29 in Q2 2025, down 37.21% year-on-year from 0.46 in Q2 2024, and down 37.21% quarter-over-quarter from 0.46 in Q2 2024.
Basel Medical (BMGL) Equity Ratio (2024 - 2025) Analysis & Trends
Basel Medical has disclosed Equity Ratio across 2 years of filings, most recently posting 0.29 for Q2 2025.
- Equity Ratio for Q2 2025 came in at 0.29, down 37.21% year-over-year; the trailing twelve-month figure through Jun 2025 was 0.29 (down 37.21% YoY), and the FY2025 annual result was 0.29, down 37.11% from the prior year.
- Equity Ratio came in at 0.29 for Q2 2025 at Basel Medical, down from 0.46 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.46 in Q2 2024 to a low of 0.29 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | -0.05 |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 0.15 |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | -0.03 |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 0.45 |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 0.42 |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 0.48 |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 0.46 |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 0.55 |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 0.18 |
| 10 | Basel Medical | 8.86 Mn | 6.52 Mn | - | 0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.29 |
| Jun 30, 2024 | 0.46 |